Clinical Trials List
Protocol NumberCAIN457M2301
Completed
2019-04-26 - 2023-04-23
Phase III
Recruiting2
ICD-10L73.2
Hidradenitis suppurativa
ICD-9705.83
Hidradenitis
-
Trial Applicant
NOVARTIS (TAIWAN) CO., LTD.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/02/01
Investigators and Locations
Co-Principal Investigator
- TSEN-FANG TSAI Division of Dermatology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 吳吉妮 Division of Dermatology
- 李勇毅 無
- Yu-Huei Huang Division of Dermatology
- Chin-Yi Yang Division of Dermatology
- Wen-Hung Chung Division of Dermatology
- Chun-Wei Lu Division of Dermatology
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
10 participants
-
Global
471 participants
